Frequency and consequences of early in-stent lesions after carotid artery stent placement

Lisa M Jongen1, Jeroen Hendrikse, Annet Waaijer

  • 1Department of Radiology, University Medical Center Utrecht, Heidelberglaan, The Netherlands. L.Jongen@umcutrecht.nl

Insights

In-stent lesions after carotid artery stenting occur in about 20% of patients one month post-procedure. These early lesions do not increase the risk of stroke or restenosis within one year.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Cardiology

Background:

  • Carotid artery stenosis is a significant risk factor for ischemic stroke.
  • Carotid artery stenting (CAS) is an alternative to endarterectomy for treating symptomatic stenosis.
  • In-stent lesions can occur after CAS, but their clinical significance is not fully understood.

Purpose of the Study:

  • To determine the prevalence of in-stent lesions one month after CAS using multidetector CT angiography.
  • To investigate the causes and consequences of these early in-stent lesions over a one-year follow-up period.

Main Methods:

  • Sixty-nine patients with symptomatic carotid artery stenosis underwent CAS.
  • Multidetector CT angiography was performed one month post-stenting to identify in-stent lesions.
  • Patients were followed for one year, with duplex ultrasonography used to assess restenosis.

Main Results:

  • In-stent lesions were detected in 14% of patients (20%) at one month.
  • One stent was occluded; other lesions did not cause significant lumen reduction.
  • No significant difference in ischemic events or restenosis at one year was observed between patients with and without early in-stent lesions.

Conclusions:

  • In-stent lesions are common one month after CAS, found in approximately one-fifth of patients.
  • These early lesions do not appear to be associated with an increased risk of recurrent ischemic events or restenosis at one year.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...